The Economics of Pharmacogenomic Testing
Enrollment options
This online, self-paced, text-based module educates healthcare professionals towards a better understanding of the benefits and limitations of direct-to-consumer pharmacogenomic testing, when to pursue confirmatory clinical testing, and how to interpret pharmacogenomic test results using evidence-based resources.
It was developed by the National Human Genome Research Institute (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG).
To access, log in to our site (to right of this page; free registration) and click 'continue' to enroll (it's free!).
Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series: Course Directors
Karen Niemchick, PhD, MHS
Grand Valley State University
Additional Content Reviewers
TARGET AUDIENCE
All healthcare professionals
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:- Understand a basic cost analysis
- Compare benefits of genetic testing with traditional treatment.
- Gain experience in accessing genetic test information.